Valuation: ABL Diagnostics

Market Cap 4.02Cr 4.6Cr 3.71Cr 3.43Cr 6.46Cr 441.56Cr 6.58Cr 44Cr 17Cr 216.22Cr 17Cr 17Cr 744.49Cr P/E 2024
123x
P/E 2025 50x
Enterprise Value 4.11Cr 4.7Cr 3.8Cr 3.51Cr 6.61Cr 451.81Cr 6.73Cr 45Cr 18Cr 221.24Cr 18Cr 17Cr 761.78Cr EV / Sales 2024
70,98,474x
EV / Sales 2025 61,85,843x
Free-Float
2.52%
Yield 2024
2.03%
Yield 2025 3.67%
1 week-6.72%
Current month-10.07%
1 month-8.09%
3 months-9.42%
6 months-30.56%
Current year-16.67%
1 week 2.4
Extreme 2.4
2.62
1 month 2.2
Extreme 2.2
2.96
Current year 2.12
Extreme 2.12
5
1 year 2.12
Extreme 2.12
5.75
3 years 2.12
Extreme 2.12
9.7
5 years 1.99
Extreme 1.9875
26
10 years 1.28
Extreme 1.275
26
Manager TitleAgeSince
Chief Executive Officer - -
Director TitleAgeSince
Director/Board Member - -
Chairman - -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
02/06
Advanced Biological Laboratories SA
SellCompany -57,692 0.3580%
27/05
Advanced Biological Laboratories SA
SellCompany -51,900 0.3221%
17/03
Advanced Biological Laboratories SA
SellCompany 54,745 0.3397%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-6.72%-54.13%-72.07% 4.58Cr
-2.56%-7.00%-32.49%-17.41% 16TCr
-3.79%-5.30%-11.53%-9.43% 11TCr
-2.09%-0.92%+1.55%+57.60% 5.96TCr
+0.35%-0.02%+43.33%+56.20% 5.25TCr
-2.07%-3.41%-14.75%-41.80% 4.24TCr
-5.88%-9.56% - - 3.43TCr
-5.08%+0.87%-13.03%-45.96% 2.95TCr
-1.87%+0.70%+59.73%-6.90% 2.54TCr
-19.84%-3.31%-7.76%-9.09% 2.12TCr
Average -2.08%-0.98%-3.23%-9.87% 5.32TCr
Weighted average by Cap. -2.42%-0.94%-7.50%-1.84%

Financials

2024 2025
Net sales 5.87 6.72 5.43 5.01 9.44 645.13 9.61 64.71 25.39 315.9 25.23 24.67 1.09T 7.97 9.12 7.36 6.8 12.81 875.54 13.04 87.82 34.45 428.72 34.24 33.48 1.48T
Net income 3L 3L 3L 2L 5L 3.13Cr 5L 31.44L 12.33L 1.53Cr 12.26L 11.99L 5.28Cr 10L 11.29L 9L 8L 15.87L 11Cr 16.16L 1.09Cr 42.68L 5.31Cr 42.41L 41.47L 18Cr
Net Debt 20.24L 23.16L 18.71L 17.28L 32.55L 22Cr 33.14L 2.23Cr 87.54L 11Cr 86.99L 85.07L 38Cr 9L 10.67L 9L 8L 15L 10Cr 15.27L 1.03Cr 40.34L 5.02Cr 40.09L 39.2L 17Cr
Logo ABL Diagnostics
ABL Diagnostics specializes in the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases (AIDS, viral hepatitis and tuberculosis) by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. Export accounts for 69.7% of net sales.
Employees
22
Date Price Change Volume
14/26/14 2.500 0.00% 1,587
13/26/13 €2.500 -0.79% 8,053
10/26/10 €2.520 +0.80% 2,305
09/26/09 €2.500 -1.57% 7,416
08/26/08 €2.540 -1.55% 3,611

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ABLD Stock